SCHEMBL5148325

SCHEMBL5148325

Cc1ccccc1S(=O)(=O)c1ccc(-c2ccnc(NCCN3C(=O)NC(C)(C)C3=O)n2)s1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 1/20 0.35
CLK1 P49759 1/20 0.35
ALDH1A1 P00352 8/20 0.34
PIK3CA P42336 1/20 0.33
MTOR P42345 1/20 0.33
LMNA P02545 2/20 0.32
HTT P42858 2/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
IKBKB O14920 1/20 0.32
DKK1 O94907 1/20 0.32
GSK3B P49841 1/20 0.32
KDM4E B2RXH2 1/20 0.32
PKM P14618 1/20 0.32
NPC1 O15118 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
AKT3 Q9Y243 1/20 0.32
EIF2AK2 P19525 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147371 0.91 LOXL2 (0.38) CDK2CLK1ALDH1A1LMNAHTT
SCHEMBL2980080 0.87 PIK3CA (0.34) CDK2CLK1ALDH1A1PIK3CAMTOR
SCHEMBL5145984 0.83 PLA2G7 (0.41) ALDH1A1IKBKBDKK1GSK3BAKT3
SCHEMBL5147312 0.82 IKBKB (0.42) CDK2CLK1ALDH1A1LMNAHTT
SCHEMBL5147268 0.80 CDK2 (0.37) CDK2CLK1ALDH1A1LMNAHTT
SCHEMBL5147406 0.80 CDK2 (0.37) CDK2CLK1ALDH1A1PIK3CALMNA
SCHEMBL5147322 0.79 LOXL2 (0.35) CDK2CLK1ALDH1A1LMNAMAPK1
SCHEMBL5147468 0.79 SMN1; SMN2 (0.40) CDK2CLK1ALDH1A1LMNAHTT
SCHEMBL5181846 0.79 AKT3 (0.37) CDK2CLK1ALDH1A1LMNAHTT
SCHEMBL2975793 0.78 LOXL2 (0.37) CDK2CLK1PIK3CAMTORMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed